Stock AVXL ANAVEX LIFE SCIENCES CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Anavex Life Sciences Corp OTC Bulletin Board

Equities

AVXL

US0327971026

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Anavex Life Sciences Corp
07-01 Anavex Life Sciences Corp.(NasdaqGS:AVXL) added to Russell Small Cap Comp Value Index CI
07-01 Anavex Life Sciences Corp.(NasdaqGS:AVXL) added to Russell 2500 Value Index CI

Chart calendar Anavex Life Sciences Corp

288f7f8.Bgh6ErEXPUjP6s5M5X-7InfmYsPTulbRIasjdqKPoSY.R1IsIoNGBCOYg7R8qRTZZBqzKZyb8i7jY59zOMXX7wtpZiAn631nBfyurQ~3eb7c2e19bf2136e3449ed9e1c2f38d9

Upcoming events on Anavex Life Sciences Corp

07/08/2024 Q3 2024 Earnings Release (Projected)
24/11/2024 Q4 2024 Earnings Release (Projected)
05/02/2025 Q1 2025 Earnings Release (Projected)
07/05/2025 Q2 2025 Earnings Release (Projected)

Past events on Anavex Life Sciences Corp

27/06/2024 12:00 H.C. Wainwright Neuro Perspectives Virtual Conference
17/06/2024 Annual General Meeting
20/05/2024 15:00 H.C. Wainwright BioConnect Investor Conference
14/05/2024 EF Hutton Investor Conference
09/05/2024 13:30 Q2 2024 Earnings Call
09/05/2024 12:30 Q2 2024 Earnings Release
18/04/2024 18:30 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
08/04/2024 13:45 Needham Healthcare Conference
04/03/2024 18:30 TD Cowen Health Care Conference
07/02/2024 13:30 Q1 2024 Earnings Call
07/02/2024 12:30 Q1 2024 Earnings Release
11/01/2024 18:30 JPMorgan Healthcare Conference
27/11/2023 13:30 Q4 2023 Earnings Call
27/11/2023 13:00 Q4 2023 Earnings Release
08/08/2023 13:30 Q3 2023 Earnings Call
08/08/2023 12:30 Q3 2023 Earnings Release
07/08/2023 17:30 BTIG Virtual Biotechnology Conference
26/06/2023 12:00 H.C. Wainwright Neuropsychiatry Conference - Fireside Chat
22/05/2023 Annual General Meeting
09/05/2023 13:30 Q2 2023 Earnings Call

Annual results

Fiscal PeriodSeptember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		-51,0
-48,0
-6.22%		-55,8
-57,0
2.18%
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-31,1
-31,9
2.39%		-42,0
-40,8
-2.88%		-51,0
-48,8
-4.38%		-55,8
-56,6
1.41%
-51,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-26,3
-29,8
11.86%		-37,6
-36,6
-2.72%		-47,6
-48,1
0.96%		-47,5
-50,7
6.3%
-43,4

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-26,3
-29,5
10.81%		-37,9
-37,1
-2.26%		-48,0
-47,8
-0.37%		-47,5
-50,7
6.36%
-43,6

EPS
USD		Released
Forecast
Spread 		-0,54
-0,62
12.9%		-0,45
-0,51
11.76%		-0,54
-0,54
-0.93%		-0,62
-0,62
0%		-0,60
-0,64
5.51%
-0,52

Announcement Date16/12/1928/12/2024/11/2128/11/2227/11/23-

Quarterly results

Fiscal PeriodSeptember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-11,5
-13,0
11.48%		-12,5
-13,1
4.79%		-15,3
-13,1
-16.7%		-15,4
-15,0
-2.39%		-14,2
-15,0
5.41%		-13,5
-14,0
3.35%		-12,7
-13,0
2.67%


-12,5
-11,5
-9.34%
-13,2


-14,6










Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-10,4
-12,7
17.72%		-12,3
-12,9
4.85%		-14,1
-13,0
-8.25%		-13,0
-15,0
13.44%		-13,1
-14,1
7.4%		-11,2
-13,3
15.5%		-10,2
-12,1
15.61%


-10,4
-9,35
-11.67%
-11,4


-13,0










Net income
Million USD		Released
Forecast
Spread 		-10,4
-13,0
19.69%		-12,4
-12,8
3.41%		-14,3
-13,4
-6.93%		-13,0
-15,0
13.57%		-13,1
-14,1
7.04%		-11,3
-13,3
15.19%		-10,1
-12,1
16.14%


-10,5
-9,35
-12.79%
-11,4


-13,0










EPS
USD		Released
Forecast
Spread 		-0,14
-0,17
17.65%		-0,16
-0,17
3.03%		-0,18
-0,17
-5.88%		-0,17
-0,19
10.53%		-0,17
-0,18
5.56%		-0,14
-0,17
17.65%		-0,12
-0,15
20%		-0,11
-0,15
26.67%		-0,13
-0,11
-18.18%
-0,14


-0,15


-0,19


-0,20


-0,23

Announcement Date10/05/2209/08/2228/11/2207/02/2309/05/2308/08/2327/11/2307/02/2409/05/24-----

Upcoming sector events for Anavex Life Sciences Corp

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 EXELIXIS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Anavex Life Sciences Corp

11/07/2024 21:00 NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release
08/07/2024 LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release
07/07/2024 TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release
04/07/2024 PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release
06/06/2024 LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release
06/06/2024 TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release
05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. AVXL Stock
  4. AVXL Stock
  5. Calendar Anavex Life Sciences Corp